YK-11 is a unique compound acting both as a partial androgen receptor agonist and as a myostatin inhibitor, distinguishing it from conventional SARMs. Research has examined YK-11 for its dual mechanism — androgenic receptor pathway activation alongside suppression of the myostatin (GDF-8) pathway that normally limits muscle growth. Preclinical in-vitro research has demonstrated YK-11's capacity to strongly induce follistatin expression and promote muscle cell differentiation. Its combined SARM/myostatin inhibitor profile makes it a unique and highly studied research compound. PeptideBull provides YK-11 at research-grade purity. Not for human or veterinary consumption.
Research Articles
BPC-157 Research Mechanisms: A Deep Dive into Healing Pathways
Discover the scientific foundation behind BPC-157's healing potential. This article explores the key research mechanisms...
Adipotide FTPP: Targeting Adipose Vasculature Research
Adipotide FTPP is a novel research peptide investigated for its effects on adipose tissue. This article delves into its...
Thymosin Alpha-1 Immune Modulation Research: A Deep Dive for Scientists
Thymosin Alpha-1 (TA1) is a naturally occurring thymic peptide extensively studied for its profound immunomodulatory pro...